We are live on ! Find out more
AGN

Allergan Inc
AGN

Delisted

AGN was delisted on the 16th of March, 2015.

13 hedge funds and large institutions have $13.9M invested in Allergan Inc in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

43% less funds holding

Funds holding: 2313 (-10)

48% less capital invested

Capital invested by funds: $26.8M → $13.9M (-$12.9M)

75% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 12

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
13
Holders Change
-10
Holders Change %
-43.48%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
3
Reduced
3
Closed
12
Calls
Puts
Net Calls
Net Calls Change

AGN Hedge Fund Activity: Q2 2016 in Review

13 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q2 2016, worth a combined $13.9M — down 48% from $26.8M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of AGN and 3 opened new positions — a net loss of 9 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Frontier Investment Management, opening a new position worth an estimated $7.57M. The largest seller was Sand Grove Capital Management, exiting entirely with an estimated $9.16M sold.

  • 13 institutional investors held Allergan Inc (AGN) as of Q2 2016, down from 23 in Q1 2016.
  • Funds reported $13.9M of Allergan Inc stock for Q2 2016, down 48% quarter-over-quarter.
  • 3 funds opened new Allergan Inc positions in Q2 2016 and 12 closed out, a net change of -9 holders.
  • The largest Allergan Inc buyer in Q2 2016 was Frontier Investment Management, an estimated $7.57M added.
  • The largest Allergan Inc seller in Q2 2016 was Sand Grove Capital Management, an estimated $9.16M sold.

Based on aggregated 13F filings for Q2 2016.